naa a22 4500 510763456 CHVBK 20180411083148.0 cr unu---uuuuu 180411e20130701xx s 000 0 eng 10.1007/s12094-012-0995-8 doi (NATIONALLICENCE)springer-10.1007/s12094-012-0995-8 GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012 [Elektronische Daten] [A. González Martín, A. Redondo, M. Jurado, A. De Juan, I. Romero, I. Bover, J. Del Campo, A. Cervantes, Y. García, J. López-Guerrero, C. Mendiola, J. Palacios, M. Rubio, A. Poveda Velasco] In 2006, under the auspices of The Spanish Research Group for Ovarian Cancer (Spanish initials GEICO), the first "Treatment Guidelines in Ovarian Cancer” were developed and then published in Clinical and Translational Oncology by Poveda Velasco et al. (Clin Transl Oncol 9(5):308-316, 2007). Almost 6years have elapsed and over this time, we have seen some important developments in the treatment of ovarian cancer. Significant changes were also introduced after the GCIG-sponsored 4th Consensus Conference on Ovarian Cancer by Stuart et al. (Int J Gynecol Cancer 21:750-755, 2011). So we decided to update the treatment guidelines in ovarian cancer and, with this objective, a group of investigators of the GEICO group met in February 2012. This study summarizes the presentations, discussions and evidence that were reviewed during the meeting and during further discussions of the manuscript. The Author(s), 2013 Ovarian cancer nationallicence Treatment guidelines nationallicence Chemotherapy nationallicence Surgery nationallicence First line nationallicence Recurrent disease nationallicence González Martín A. Medical Oncology Department, MD Anderson Cancer Center, C/Arturo Soria, 270, 28033, Madrid, Spain aut Redondo A. Medical Oncology Department, University Hospital La Paz, Madrid, Spain aut Jurado M. Department of Gynecology, School of Medicine, University of Navarra, Pamplona, Spain aut De Juan A. Department of Medical Oncology, University Hospital Marqués de Valdecilla, Santander, Spain aut Romero I. Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain aut Bover I. Medical Oncology Department, Hospital Son Llàtzer, Palma de Mallorca, Islas Baleares, Spain aut Del Campo J. Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain aut Cervantes A. Department of Hematology and Medical Oncology, Institute of Health Research INCLIVA, Hospital Clínico Universitario, University of Valencia, Valencia, Spain aut García Y. Department of Medical Oncology, Sabadell Hospital, Parc Taulí Healthcare Corporation, Sabadell, Barcelona, Spain aut López-Guerrero J. Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain aut Mendiola C. Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain aut Palacios J. Department of Pathology, University Hospital Ramón y Cajal, Madrid, Spain aut Rubio M. Department of Medical Oncology, University Hospital Reina Sofía, Córdoba, Spain aut Poveda Velasco A. Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain aut Clinical and Translational Oncology Springer Milan 15/7(2013-07-01), 509-525 1699-048X 15:7<509 2013 15 12094 https://doi.org/10.1007/s12094-012-0995-8 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s12094-012-0995-8 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- González Martín A. Medical Oncology Department, MD Anderson Cancer Center, C/Arturo Soria, 270, 28033, Madrid, Spain aut NATIONALLICENCE 700 1- Redondo A. Medical Oncology Department, University Hospital La Paz, Madrid, Spain aut NATIONALLICENCE 700 1- Jurado M. Department of Gynecology, School of Medicine, University of Navarra, Pamplona, Spain aut NATIONALLICENCE 700 1- De Juan A. Department of Medical Oncology, University Hospital Marqués de Valdecilla, Santander, Spain aut NATIONALLICENCE 700 1- Romero I. Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain aut NATIONALLICENCE 700 1- Bover I. Medical Oncology Department, Hospital Son Llàtzer, Palma de Mallorca, Islas Baleares, Spain aut NATIONALLICENCE 700 1- Del Campo J. Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain aut NATIONALLICENCE 700 1- Cervantes A. Department of Hematology and Medical Oncology, Institute of Health Research INCLIVA, Hospital Clínico Universitario, University of Valencia, Valencia, Spain aut NATIONALLICENCE 700 1- García Y. Department of Medical Oncology, Sabadell Hospital, Parc Taulí Healthcare Corporation, Sabadell, Barcelona, Spain aut NATIONALLICENCE 700 1- López-Guerrero J. Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain aut NATIONALLICENCE 700 1- Mendiola C. Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain aut NATIONALLICENCE 700 1- Palacios J. Department of Pathology, University Hospital Ramón y Cajal, Madrid, Spain aut NATIONALLICENCE 700 1- Rubio M. Department of Medical Oncology, University Hospital Reina Sofía, Córdoba, Spain aut NATIONALLICENCE 700 1- Poveda Velasco A. Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain aut NATIONALLICENCE 773 0- Clinical and Translational Oncology Springer Milan 15/7(2013-07-01), 509-525 1699-048X 15:7<509 2013 15 12094 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer